|
Re: Covid China
|
4
|
Resverlogix Corp.
|
Mar 30, 2022 07:31AM
|
|
Re: Covid China
|
6
|
Resverlogix Corp.
|
Mar 30, 2022 12:36PM
|
|
Re: Self Financing
|
8
|
Resverlogix Corp.
|
Apr 01, 2022 08:59PM
|
|
Re: Veru vs Resverlogix
|
7
|
Resverlogix Corp.
|
Apr 16, 2022 08:09PM
|
|
Re: Extension of debenture!
|
3
|
Resverlogix Corp.
|
Apr 20, 2022 06:22AM
|
|
Re: BTD
|
6
|
Resverlogix Corp.
|
Apr 23, 2022 11:43PM
|
|
Re: BTD
|
6
|
Resverlogix Corp.
|
Apr 24, 2022 03:54PM
|
|
Re: BTD
|
2
|
Resverlogix Corp.
|
Apr 25, 2022 08:29AM
|
|
Re: BTD
|
7
|
Resverlogix Corp.
|
Apr 25, 2022 12:10PM
|
|
Re: BTD
|
5
|
Resverlogix Corp.
|
Apr 25, 2022 07:00PM
|
|
Re: New Apabetalone Fabry Disease Publication
|
5
|
Resverlogix Corp.
|
Apr 28, 2022 07:05AM
|
|
Re: New Apabetalone Fabry Disease Publication
|
1
|
Resverlogix Corp.
|
Apr 28, 2022 07:14AM
|
|
Re: New Apabetalone Fabry Disease Publication
|
5
|
Resverlogix Corp.
|
Apr 29, 2022 01:11PM
|
|
Re: New Apabetalone Fabry Disease Publication
|
2
|
Resverlogix Corp.
|
Apr 29, 2022 02:52PM
|
|
Re: Market Woes
|
3
|
Resverlogix Corp.
|
May 01, 2022 01:25PM
|
|
Re: Pfizer sees strong demand for COVID pill as profits surge.
|
5
|
Resverlogix Corp.
|
May 04, 2022 08:54PM
|
|
Re: " Resverlogix will conclude its Phase 2 trial in hospitalized COVID-19 patients early, thus focusing its resources on the advanced Phase 3 program."
|
6
|
Resverlogix Corp.
|
May 09, 2022 08:09AM
|
|
Re: RVX ANNOUNCES TYPE C MEETING WITH FDA FOR CORAL, A PHASE 3 HIGH-RISK COVID-19 OUTPATIENT STUDY
|
4
|
Resverlogix Corp.
|
May 09, 2022 12:26PM
|
|
Re: Type C Meeting
|
6
|
Resverlogix Corp.
|
May 12, 2022 09:47AM
|
|
Re: Type C Meeting
|
4
|
Resverlogix Corp.
|
May 12, 2022 12:16PM
|
